AGILON HEALTH (AGL)
Health Care · Medicare Advantage and value-based care platform / primary care risk organization · NYSE
Agilon empowers primary care physicians to take financial and clinical risk for managing total healthcare costs under Medicare capitation, using technology and data to drive quality and profitability.
What AGILON HEALTH does
Agilon Health operates a platform that empowers primary care physicians to manage total healthcare needs under a Medicare-centric, globally capitated payment model. The company forms risk-bearing entities in local geographies that contract with payors (primarily Medicare Advantage) to manage attributed patient populations, partnering long-term with anchor physician groups and independent practice associations. As of December 31, 2025, the platform served approximately 511,000 MA members and 114,000 Medicare fee-for-service beneficiaries across 28 anchor physician groups and 30 geographies. Agilon provides integrated technology, operational infrastructure, and capital to transition physicians to a Total Care Model focused on quality improvement and cost reduction.
Themes: ["Primary care transformation / physician enablement","Medicare Advantage risk contracting","Value-based care / global capitation","Healthcare cost and quality management","ACO / Accountable Care Organizations"]
Fundamentals
- Price$115.67 as of 2026-07-09 close
- Market cap$1.9B as of 2026-07-10
- 1-year return+87.1% as of 2026-07-09 close
- Net margin-6.1% as of 2026-07-10
- Gross margin-0.4% as of 2026-07-10
- ROE-138.6% as of 2026-07-10
- Debt / equity0.17 as of 2026-07-10
- Revenue growth (YoY)-2.8% as of 2026-07-10
- Revenue CAGR (3y)+35.4% SEC XBRL
- Beta3.03 as of 2026-07-10
Key risks (from latest filing)
["Regulatory and reimbursement risk: Dependence on Medicare Advantage and CMS payment models (ACO REACH, MSSP); changes in capitation rates, coverage policies, or payor willingness to enter global risk arrangements could significantly impact revenue and profitability.","Stock delisting risk: The company received NYSE noncompliance notice in November 2025 for failing the $1.00 minimum share price requirement and is pursuing a reverse stock split for cure; delisting would adversely impact trading liquidity and market price.","Medical claims and operational leverage risk: Medical services expenses represent the largest component of costs; significant adverse medical loss ratios or underwriting losses in risk-bearing entities could materially impair earnings, evidenced by unprofitability and accumulated deficit of ~$1.93 billion as of March 31, 2026."]
Competitors & peers
- Humana (HUM)
- UnitedHealth Group / Optum (UNH)
- CVS Health / Aetna (CVS)
- Elevance Health / Anthem (ELV)
- Oak Street Health
- Contigo Health
- Privia Health (PRVA)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.